Public Comments

Publish Date
Public Comments
C4IP Comments RE: Business Collaborations (ATR-2026-0001)
Public Comments
C4IP Post-Hearing Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise
Public Comments
C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025)
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Public Comments
C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011)
Public Comments
C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program
Public Comments
C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048)
Public Comments
C4IP Written Submission RE: Inv. No. 337-TA-1380
C4IP:

C4IP:

C4IP Comments RE: Business Collaborations (ATR-2026-0001),

05/22/2026

Resources:

Resources:

C4IP Post-Hearing Comments RE: The 2026 Special 301 Review (USTR-2025-0243),

02/25/2026

Resources:

Resources:

C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243),

01/28/2026

Resources:

Resources:

C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise,

12/26/2025

Resources:

Resources:

C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025),

12/02/2025

Resources:

Resources:

C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime,

11/06/2025

Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025

Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Resources:

Resources:

C4IP Comments RE: The World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (PTO-C-2024-0048),

03/18/2025

Resources:

Resources:

C4IP Written Submission RE: Inv. No. 337-TA-1380,

03/13/2025

Scroll to Top